An analysis of the support and quality of live after the diagnosis and treatment of prostate cancer in the radiotherapy sector
DOI:
https://doi.org/10.15392/bjrs.v9i1A.1384Keywords:
radiotherapy 1, support 2, quality of life 3, prostate cancer 4Abstract
Prostate cancer is the most common chronic disease among men in most parts of the world. According to the National Cancer Institute (INCA) in Brazil in 2018, 68,000 new cases were registered. Among the main treatments the radiotherapy has been shown to be effective in controlling and curing the disease. However, it is noted that the patient satisfaction index is not the most encouraging and there is little research that points to the sup-port of the hospital team. The aim of this study was to collect data from medical records about the adverse effect of the disease and through questionnaire the level of knowledge about the disease and the support offered by sector and to make recommendations for radiotherapy units Data were collected from 147 patients and of that total, 51 answered the questionnaire. The survey also shows that there was little referral to the complementary therapeutic service during of treatment. It is identified that more than 50% them knew very little about prostate cancer and 42% had no participation in the choice of treatment. It is observed that it is difficult to insert support policies for patients with prostate cancer, the professionals who work in oncology and radiotherapy centers underestimate the effects of the disease. It is observed, through research, that many of the symptoms and debilitations could be mitigated if there was a greater interaction between the health team and the patient, reducing the effects of radiation and accelerating the patient's integration for the social environment.
- Views: 83
- PDF Downloads: 122
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Brazilian Journal of Radiation Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing: The BJRS articles are licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/